Liver Injury/Regeneration

You have full text access to this OnlineOpen article

Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury†

  1. Barbara A. Wetmore1,‡,
  2. Dominique J. Brees2,‡,
  3. Reetu Singh1,
  4. Paul B. Watkins1,
  5. Melvin E. Andersen1,
  6. James Loy3,
  7. Russell S. Thomas1,§,*

Article first published online: 3 FEB 2010

DOI: 10.1002/hep.23574

Issue

Hepatology

Hepatology

Volume 51, Issue 6, pages 2127–2139, June 2010

Additional Information

How to Cite

Wetmore, B. A., Brees, D. J., Singh, R., Watkins, P. B., Andersen, M. E., Loy, J. and Thomas, R. S. (2010), Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology, 51: 2127–2139. doi: 10.1002/hep.23574

Author Information

  1. 1

    The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina

  2. 2

    Pfizer, Sandwich, Kent, UK

  3. 3

    Bristol-Myers Squib, Wallingford, Connecticut

  1. ‡

    The first two authors contributed equally to this work.

  2. §

    fax: (919) 558-1300

*The Hamner Institutes for Health Sciences, 6 Davis Drive, P.O. Box 12137, Research Triangle Park, NC 27709-2137

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 23 MAY 2010
  2. Article first published online: 3 FEB 2010
  3. Accepted manuscript online: 3 FEB 2010 12:00AM EST
  4. Manuscript Accepted: 19 JAN 2010
  5. Manuscript Received: 7 OCT 2009

Funded by

  • National Center for Research Resources. Grant Number: #50KR10957
  • The Hamner Institutes Pilot Projects Initiative and a contract from Pfizer Global Research and Development (Groton, CT)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (1784K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cynthia Ju, Timothy Reilly, Role of immune reactions in drug-induced liver injury (DILI), Drug Metabolism Reviews, 2012, 44, 1, 107

    CrossRef

  2. 2
    Richard A. Currie, Toxicogenomics: The challenges and opportunities to identify biomarkers, signatures and thresholds to support mode-of-action, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2012, 746, 2, 97

    CrossRef

  3. 3
    R. Sellamuthu, C. Umbright, J. R. Roberts, R. Chapman, S.-H. Young, D. Richardson, H. Leonard, W. McKinney, B. Chen, D. Frazer, S. Li, M. Kashon, P. Joseph, Blood Gene Expression Profiling Detects Silica Exposure and Toxicity, Toxicological Sciences, 2011, 122, 2, 253

    CrossRef

  4. 4
    Thomas A. Kerr, Kevin M. Korenblat, Nicholas O. Davidson, MicroRNAs and liver disease, Translational Research, 2011, 157, 4, 241

    CrossRef

  5. 5
    Deidre A. Dalmas, Marshall S. Scicchitano, David Mullins, Angela Hughes-Earle, Kay Tatsuoka, Michal Magid-Slav, Kendall S. Frazier, Heath C. Thomas, Potential candidate genomic biomarkers of drug induced vascular injury in the rat, Toxicology and Applied Pharmacology, 2011, 257, 2, 284

    CrossRef

  6. 6
    Shashi K. Ramaiah, Preclinical Safety Assessment: Current Gaps, Challenges, and Approaches in Identifying Translatable Biomarkers of Drug-Induced Liver Injury, Clinics in Laboratory Medicine, 2011, 31, 1, 161

    CrossRef

  7. You have free access to this content7
    J. S. Au, V. J. Navarro, S. Rossi, Review article: drug-induced liver injury – its pathophysiology and evolving diagnostic tools, Alimentary Pharmacology & Therapeutics, 2011, 34, 1
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (1784K)